136 related articles for article (PubMed ID: 11876549)
21. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
22. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
[TBL] [Abstract][Full Text] [Related]
23. Hyperplastic-like mucosal change in Crohn's disease: an unusual form of dysplasia?
Kilgore SP; Sigel JE; Goldblum JR
Mod Pathol; 2000 Jul; 13(7):797-801. PubMed ID: 10912940
[TBL] [Abstract][Full Text] [Related]
24. Expression pattern of vascular endothelial growth factor-C in human colorectal normal mucosa and neoplastic mucosa.
Kazama S; Kitayama J; Watanabe T; Nagawa H
Hepatogastroenterology; 2004; 51(56):391-5. PubMed ID: 15086167
[TBL] [Abstract][Full Text] [Related]
25. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y
Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma.
Komatsu K; Kobune-Fujiwara Y; Andoh A; Ishiguro S; Hunai H; Suzuki N; Kameyama M; Murata K; Miyoshi J; Akedo H; Tatsuta M; Nakamura H
Br J Cancer; 2000 Sep; 83(6):769-74. PubMed ID: 10952782
[TBL] [Abstract][Full Text] [Related]
27. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas.
Sahin AA; Ro JY; Brown RW; Ordonez NG; Cleary KR; el-Naggar AK; Wilson P; Ayala AG
Mod Pathol; 1994 Jan; 7(1):17-22. PubMed ID: 8159647
[TBL] [Abstract][Full Text] [Related]
29. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
30. Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer.
Mukai M; Sato S; Komatsu N; Nishida T; Shiba K; Ito I; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(5):1177-81. PubMed ID: 12883677
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of Smac/DIABLO expression in colorectal cancer.
Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
[TBL] [Abstract][Full Text] [Related]
32. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer.
Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Inoue K; Nagayasu T; Sekine I
Oncol Rep; 2006 Jun; 15(6):1445-51. PubMed ID: 16685378
[TBL] [Abstract][Full Text] [Related]
33. [Expression of cathepsin B and its clinical importance in colorectal cancer].
Yu B; Li SY; An P; Zuo FY; Cai HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):507-9. PubMed ID: 16299652
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Ki-67 and Bcl-2 protein expression in normal colorectal mucosa of women with breast cancer.
Sousa-Júnior EC; Alencar AP; da Silva BB
Eur J Cancer; 2009 Nov; 45(17):3081-6. PubMed ID: 19786344
[TBL] [Abstract][Full Text] [Related]
35. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
36. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
37. Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer.
Mukai M; Sato S; Komatsu N; Nishida T; Shiba K; Ito I; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(5):1165-9. PubMed ID: 12883675
[TBL] [Abstract][Full Text] [Related]
38. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
39. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
[TBL] [Abstract][Full Text] [Related]
40. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]